Cory H White
Overview
Explore the profile of Cory H White including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
33
Citations
548
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Garay-Baquero D, White C, Walker N, Tebruegge M, Schiff H, Ugarte-Gil C, et al.
JCI Insight
. 2020 Aug;
5(18).
PMID: 32780727
BACKGROUNDTuberculosis (TB) kills more people than any other infection, and new diagnostic tests to identify active cases are required. We aimed to discover and verify novel markers for TB in...
12.
Jacob B Geri , Oakley J, Reyes-Robles T, Wang T, McCarver S, White C, et al.
Science
. 2020 Mar;
367(6482):1091-1097.
PMID: 32139536
Many disease pathologies can be understood through the elucidation of localized biomolecular networks, or microenvironments. To this end, enzymatic proximity labeling platforms are broadly applied for mapping the wider spatial...
13.
Trypsteen W, White C, Mukim A, Spina C, De Spiegelaere W, Lefever S, et al.
PLoS One
. 2019 Nov;
14(11):e0224879.
PMID: 31710657
The latent cellular reservoir of HIV is recognized as the major barrier to cure from HIV infection. Long non-coding RNAs (lncRNAs) are more tissue and cell type-specific than protein coding...
14.
Beliakova-Bethell N, Mukim A, White C, Deshmukh S, Abewe H, Richman D, et al.
J Biol Chem
. 2019 Feb;
294(14):5576-5589.
PMID: 30745362
Histone deacetylase (HDAC) inhibitors (HDACis) have been widely tested in clinical trials for their ability to reverse HIV latency but have yielded only limited success. One HDACi, suberoylanilide hydroxamic acid...
15.
White C, Beliakova-Bethell N, Lada S, Breen M, Hurst T, Spina C, et al.
Front Immunol
. 2018 May;
9:603.
PMID: 29706951
The greatest obstacle to a cure for HIV is the provirus that integrates into the genome of the infected cell and persists despite antiretroviral therapy. A "shock and kill" approach...
16.
Manousopoulou A, Hayden A, Mellone M, Garay-Baquero D, White C, Noble F, et al.
Br J Cancer
. 2018 Mar;
118(9):1200-1207.
PMID: 29593339
Background: Cancer-associated fibroblasts (CAFs) form the major stromal component of the tumour microenvironment (TME). The present study aimed to examine the proteomic profiles of CAFs vs. normal fibroblasts (NOFs) from...
17.
Zeidan B, Manousopoulou A, Garay-Baquero D, White C, Larkin S, Potter K, et al.
Breast Cancer Res
. 2018 Mar;
20(1):19.
PMID: 29566726
Background: Early-onset breast cancer (EOBC) affects about one in 300 women aged 40 years or younger and is associated with worse outcomes than later onset breast cancer. This study explored...
18.
White C, Moesker B, Beliakova-Bethell N, Martins L, Spina C, Margolis D, et al.
PLoS Pathog
. 2016 Nov;
12(11):e1006026.
PMID: 27898737
The search for an HIV-1 cure has been greatly hindered by the presence of a viral reservoir that persists despite antiretroviral therapy (ART). Studies of HIV-1 latency in vivo are...
19.
Myint A, White C, Ohmen J, Li X, Wang J, Lavinsky J, et al.
Hear Res
. 2015 Dec;
332:113-120.
PMID: 26706709
A cornerstone technique in the study of hearing is the Auditory Brainstem Response (ABR), an electrophysiologic technique that can be used as a quantitative measure of hearing function. Previous studies...
20.
White C, Johnston H, Moesker B, Manousopoulou A, Margolis D, Richman D, et al.
Antiviral Res
. 2015 Sep;
123:78-85.
PMID: 26343910
Suberoylanilide hydroxamic acid (SAHA) has been assessed in clinical trials as part of a "shock and kill" strategy to cure HIV-infected patients. While it was effective at inducing expression of...